Article Information
History
- November 14, 2018.
Article Versions
- Version 1 (January 27, 2018 - 04:15).
- Version 2 (October 25, 2018 - 12:35).
- Version 3 (October 28, 2018 - 12:50).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Kent Miner1,
- Katja Labitzke2,†,
- Benxian Liu1,
- Paul Wang2,
- Kathryn Henckels1,
- Kevin Gaida1,
- Robin Elliott1,
- Jian Jeffrey Chen3,
- Longbin Liu3,†,
- Anh Leith1,†,
- Esther Trueblood4,†,
- Kelly Hensley4,
- Xing-Zhong Xia1,
- Oliver Homann5,
- Brian Bennett1,
- Mike Fiorino1,
- John Whoriskey1,
- Gang Yu1,
- Sabine Escobar1,
- Min Wong1,
- Teresa L. Born1,†,
- Alison Budelsky1,†,
- Mike Comeau1,
- Dirk Smith1,†,
- Jonathan Phillips1,
- James A. Johnston1,
- Joe McGivern2,
- Kerstin Weikl2,†,
- David Powers2,
- Karl Kunzelmann6,
- Deanna Mohn1,*,
- Andreas Hochheimer2,†,* and
- John K. Sullivan1,†,*
- 1Department of Inflammation Research, Amgen Inc., Thousand Oaks, CA and Seattle, WA, USA
- 2Department of Therapeutic Discovery, Amgen Inc., Thousand Oaks, CA, USA and Regensburg, Germany
- 3Department of Medicinal Chemistry, Amgen Inc., Thousand Oaks, CA, USA
- 4Department of Comparative Biology and Safety Sciences, Amgen Inc., Seattle, WA, Thousand Oaks, CA and South San Francisco, CA, USA
- 5Genome Analysis Unit, Amgen Inc., South San Francisco, CA, USA
- 6Institut für Physiologie, Universität Regensburg, Regensburg, Germany
- ↵*Correspondence:
John K. Sullivan, jksullivan{at}polestarbio.com, Andreas Hochheimer, andreas.hochheimer{at}isarbioscience.de; Deanna Mohn, dmohn{at}amgen.com